Epilepsy Incidence Among Children in the United States
ID: 355205Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $500K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355205

Additional Information

https://nap.nationalacademies.org/read/13379/chapter/1
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Epilepsy Incidence Among Children in the United States," aimed at estimating the incidence of epilepsy among U.S. children aged 0 to 17 and identifying disparities influenced by demographic factors and social determinants of health. The initiative seeks to conduct a comprehensive study utilizing nationwide datasets to provide insights into epilepsy incidence, risk factors, and incidence disparities, thereby informing public health policies and resource allocation. With a total funding amount of $1.6 million available for a cooperative agreement over four years, the anticipated award for the first budget year is $500,000. Interested applicants, including small businesses and various organizations, must submit their applications by January 23, 2025, with a letter of intent due by December 12, 2024. For further inquiries, applicants can contact Natalie Brown at nbrown3@cdc.gov.

    Point(s) of Contact
    nbrown3@cdc.gov
    Files
    Title
    Posted
    RFA-DP-25-038_20241106.pdf
    The Centers for Disease Control and Prevention (CDC) issued a Notice of Funding Opportunity (NOFO) titled "Epilepsy Incidence Among Children in the United States" under RFA-DP-25-038. The goal is to estimate the overall incidence of epilepsy among U.S. children aged 0 to 17 and identify disparities in incidence rates influenced by demographic factors and social determinants of health. The funding of $1.6 million is available for the cooperative agreement covering a four-year period, with an anticipated single award of $500,000 for the first budget year. Eligible applicants include various organizations such as state and local governments, public and private higher education institutions, and nonprofit organizations. The application deadline is January 23, 2025, with a letter of intent due by December 12, 2024. Researchers are encouraged to leverage advanced data science techniques, including machine learning, to ascertain epilepsy cases and identify risk factors. This initiative aligns with Healthy People 2030 objectives and CDC priorities, aiming to improve health outcomes for children with epilepsy by informing public health policy and research gaps. Evaluation of applications will be based on specific scientific merit criteria, encompassing significance, innovation, approach, investigator qualifications, and the overall impact on the field.
    Similar Opportunities
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting research proposals through a cooperative agreement to identify and evaluate potential risk factors for Amyotrophic Lateral Sclerosis (ALS). The opportunity encourages studies focusing on various aspects such as military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents, with four distinct funding options available to support both established and exploratory research. This initiative aims to enhance understanding of ALS risk factors, particularly in affected populations, and to analyze biological samples related to the Guamanian ALS cluster. Interested applicants can reach out to Dr. Candis Hunter at ncipcerpo@cdc.gov or by phone at 770-488-1347. The total estimated funding for this program is $7.5 million, with individual awards ranging from $0 to $500,000, and proposals are due by December 1, 2025, with awards expected to be announced by August 28, 2026.
    Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research aimed at investigating novel therapeutic interventions and testing strategies for neurological disorders, specifically targeting the treatment, modification, and prevention of epilepsy. This initiative encourages applicants to explore various intervention modalities and develop human-focused testing approaches, with a particular emphasis on preclinical therapy testing and model development. The total estimated program funding is $6.2 million, with individual awards ranging from $3.5 million to $4 million, and the application process is expected to open with a synopsis posted by December 19, 2025, closing on February 20, 2026. Interested applicants can reach out to Dr. Brian Klein at brian.klein@nih.gov or (301) 496-0981 for further information.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations" through a cooperative agreement. This initiative aims to support research that gathers timely economic data on immunization from nationally representative samples of the public, including patients and caregivers, to inform economic evaluations of new vaccines. The program is critical for understanding productivity losses related to immunization, particularly for vulnerable populations such as pregnant women and parents of young children. The estimated total funding for this program is $1.2 million, with individual awards ranging from $300,000 to $400,000. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 31, 2026, and project start anticipated on September 1, 2026.
    Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering grants to support new investigators in conducting research aimed at preventing interpersonal violence impacting children and youth. Applicants are required to propose research projects that align with specific NCIPC research priorities, including adverse childhood experiences, child abuse and neglect, youth violence, intimate partner violence, sexual violence, and suicide, focusing on individuals aged birth to 17 years. This funding opportunity, with an estimated total program funding of $1.8 million and an award ceiling of $150,000, is designed to foster the development of independent researchers in the field of violence prevention. Interested applicants should note that the application deadline is December 1, 2025, and can reach out to Tamara N. Crawford at ncipcerpo@cdc.gov for further information.
    US Travelers Health Research, Surveillance, and Outreach Network
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "US Travelers Health Research, Surveillance, and Outreach Network" through a cooperative agreement aimed at enhancing pre-travel health consultations for international travelers. The primary objectives are to increase the proportion of travelers receiving essential health advice and vaccinations before traveling to areas at risk for infectious diseases, thereby improving the quality of healthcare provided during these consultations. Given the rise in international travel and associated health risks, this initiative is crucial for educating travelers on preventive measures against illnesses such as yellow fever and malaria. The total funding available for this program is $3 million, with individual awards ranging from $450,000 to $600,000. Interested applicants, particularly for-profit organizations, should note that applications are due by March 1, 2026, with an estimated award date of September 15, 2026. For further inquiries, contact Amy Yang at AYang@cdc.gov or call 404-718-8836.
    Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Eliminating Parasitic and Neglected Tropical Disease Threats to the United States," aimed at expanding its network of collaborating institutes for research and program support. The initiative seeks to achieve, accelerate, or maintain outcomes for the elimination or control of non-malaria parasitic threats and neglected tropical diseases that impact the health of Americans domestically and internationally. This cooperative agreement has an estimated total program funding of $10 million, with individual awards ranging from $500,000 to $666,667, and is expected to result in three awards. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 1, 2026, and awards anticipated by September 15, 2026.
    Comprehensive Suicide Prevention Program for States
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Comprehensive Suicide Prevention Program for States," aimed at implementing and evaluating a comprehensive approach to suicide prevention, particularly for disproportionately affected populations such as veterans, rural communities, and LGBTQ individuals. Eligible applicants must submit proposals with a funding request between $650,000 and $1,200,000, including various letters of commitment and support, as well as a preliminary organizational chart detailing required staff roles. The total estimated program funding is approximately $49.7 million, with an expected 42 awards to be made, and applications must be submitted electronically by 11:59 PM ET on March 3, 2026, with the anticipated award date set for June 19, 2026. For further inquiries, applicants can contact the Comprehensive Suicide Prevention mailbox at csp@cdc.gov.
    Influenza Modeling and Forecasting
    Centers for Disease Control - NCIRD
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Influenza Modeling and Forecasting" through a cooperative agreement aimed at enhancing the use of influenza modeling and forecasting to improve public health responses. The initiative seeks to establish a network that will provide situational awareness, inform prevention and control strategies, and advance the science of influenza forecasting, particularly for populations disproportionately affected by influenza. With an estimated total program funding of $14,750,000 and the expectation of awarding seven grants, interested applicants can reach out to Rebecca Borchering at 404.639.5214 or via email at xkq2@cdc.gov. Applications must be submitted electronically by February 2, 2026, with awards anticipated to be made by August 1, 2026.